Literature DB >> 12609570

Psychological issues related to the use of spiral CT for lung cancer early detection.

Robert A Schnoll1, Pamela Bradley, Suzanne M Miller, Michael Unger, James Babb, Mark Cornfeld.   

Abstract

Although the NCI is presently investigating whether enhanced detection of lung tumors via spiral CT reduces lung cancer mortality, use of this technology for lung cancer screening is already widespread in the US. Few data are available concerning level of interest in, or awareness of, spiral CT for lung cancer screening, correlates of participation in screening, or potential reactions to screening results (i.e. smoking cessation) among high-risk individuals. One-hundred-and-seventy-two current or former smokers with no personal cancer history were queried about their awareness of spiral CT for lung cancer screening, received information about the procedure, and completed a survey that assessed interest in screening, correlates of screening interest (i.e. demographic, health, psychological), and expected effects of screening results on smoking. Seventy-seven percent of respondents were unaware of spiral CT for lung cancer screening and 62% expressed high interest in screening. Screening interest was positively related to screening self-efficacy, knowledge of asymptomatic illness, and perceived lung cancer risk. In the face of a positive scan, 52% of smokers said that they would quit, 43% said they would consider quitting, and 3% would continue smoking. If the scan was negative, 19% of smokers said that they would quit, 61% said they would consider quitting, and 20% would continue smoking. Finally, 59% of smokers were interested in smoking cessation counseling, with screening. These findings can help guide the design of psychological interventions to promote the utilization of spiral CT for early lung cancer detection as well as the development of protocols to promote behavior change within lung cancer screening programs, should future studies indicate that spiral CT screening can effectively reduce the overall lung cancer mortality rate.

Entities:  

Mesh:

Year:  2003        PMID: 12609570     DOI: 10.1016/s0169-5002(02)00501-9

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

Review 1.  Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.

Authors:  Lisa M Fucito; Sharon Czabafy; Peter S Hendricks; Chris Kotsen; Donna Richardson; Benjamin A Toll
Journal:  Cancer       Date:  2016-02-24       Impact factor: 6.860

2.  Perceptions of lung cancer risk and beliefs in screening accuracy of spiral computed tomography among high-risk lung cancer family members.

Authors:  Pamela S Sinicrope; Kari G Rabe; Tabetha A Brockman; Christi A Patten; Wesley O Petersen; Joshua Slusser; Ping Yang; Stephen J Swensen; Eric S Edell; Mariza de Andrade; Gloria M Petersen
Journal:  Acad Radiol       Date:  2010-08       Impact factor: 3.173

3.  A pilot test of a combined tobacco dependence treatment and lung cancer screening program.

Authors:  Amy K Ferketich; Gregory A Otterson; Mark King; Nathan Hall; Kristine K Browning; Mary Ellen Wewers
Journal:  Lung Cancer       Date:  2011-11-15       Impact factor: 5.705

4.  Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.

Authors:  M Pallin; S Walsh; M F O'Driscoll; C Murray; A Cahalane; L Brown; M Carter; P Mitchell; T J McDonnell; M W Butler
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

5.  CT scan screening is associated with increased distress among subjects of the APExS.

Authors:  Christophe Paris; Marion Maurel; Amandine Luc; Audrey Stoufflet; Jean-Claude Pairon; Marc Letourneux
Journal:  BMC Public Health       Date:  2010-10-26       Impact factor: 3.295

6.  Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.

Authors:  Noor Ali; Kate J Lifford; Ben Carter; Fiona McRonald; Ghasem Yadegarfar; David R Baldwin; David Weller; David M Hansell; Stephen W Duffy; John K Field; Kate Brain
Journal:  BMJ Open       Date:  2015-07-14       Impact factor: 2.692

Review 7.  Lung Cancer Screening With Low-Dose CT: Its Effect on Smoking Behavior.

Authors:  Meaghan McEntee Gomez; Geri LoBiondo-Wood
Journal:  J Adv Pract Oncol       Date:  2013-11

8.  Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

Authors:  V K Lam; R J Scott; P Billings; E Cabebe; R P Young
Journal:  Prev Med Rep       Date:  2021-05-16

Review 9.  Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.

Authors:  Anne M Joseph; Alexander J Rothman; Daniel Almirall; Abbie Begnaud; Caroline Chiles; Paul M Cinciripini; Steven S Fu; Amanda L Graham; Bruce R Lindgren; Anne C Melzer; Jamie S Ostroff; Elizabeth L Seaman; Kathryn L Taylor; Benjamin A Toll; Steven B Zeliadt; David M Vock
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 30.528

10.  Could CT screening for lung cancer ever be cost effective in the United Kingdom?

Authors:  David K Whynes
Journal:  Cost Eff Resour Alloc       Date:  2008-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.